You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Tumors

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor, Gynecological Tumors Trial in Shanghai (GT316)

Recruiting
  • Solid Tumor
  • Gynecological Tumors
  • GT316
  • Shanghai, Shanghai, China
    Shanghai Tenth People's Hospital
Nov 17, 2023

Cryoablation for Advanced and Refractory Desmoid Tumors

Recruiting
  • Desmoid Tumors
    • Strasbourg, France
      Service d'Imagerie Interventionnelle - CHU de Strasbourg - Franc
    Oct 30, 2023

    Gynecological Rare Pathological Tumors

    Not yet recruiting
    • Rare Gynecological Tumors
    • Multi-omics Analysis
      • (no location specified)
      Aug 3, 2023

      Clinical Relevance of Salvage Treatment for Colorectal

      Completed
      • Rectal Neoplasms
      • Neuroendocrine Tumors
      • salvage treatment
      • (no location specified)
      Nov 16, 2023

      Solid Tumors, Advanced Solid Tumors, Metastatic Solid Tumors Trial (INCA33890)

      Not yet recruiting
      • Solid Tumors
      • +2 more
      • (no location specified)
      Apr 26, 2023

      Viral BIOmarkers and microRNAs in Tumors Orofarynx and Occult

      Recruiting
      • Viral BIOmarkers, microRNAs, Tumors Orofarynx, Occult Tumors Positive for Papilloma Virus
      • Study of Viral BIOmarkers and microRNAs in Tumors Orofarynx
      • Rome, Italy
        "Regina Elena" National Cancer Institute
      Jun 15, 2023

      Neuroendocrine Tumors Trial in Hyderabad (Endoscopic submucosal dissection, EFTR)

      Recruiting
      • Neuroendocrine Tumors
      • Endoscopic submucosal dissection
      • EFTR
      • Hyderabad, Telangana, India
        Asian institute of Gastroenterology
      Nov 11, 2023

      Advanced Solid Tumors Trial (QL1706H)

      Not yet recruiting
      • Advanced Solid Tumors
      • (no location specified)
      Sep 18, 2023

      Breast Tumors Trial

      Not yet recruiting
      • Breast Tumors
        • (no location specified)
        Aug 2, 2023

        Advanced Solid Tumors Harboring NTRK Fusion, Primary CNS Tumors Harboring NTRK Fusion Trial in Guangzhou (ICP-723)

        Recruiting
        • Advanced Solid Tumors Harboring NTRK Fusion
        • Primary Central Nervous System Tumors Harboring NTRK Fusion
        • Guangzhou, Guangdong, China
          Sun Yat-Sen University Cancer Center
        Feb 16, 2023

        Neuroendocrine Tumors Trial in Beijing (Surufatinib Combined With Temozolomide and S-1)

        Not yet recruiting
        • Neuroendocrine Tumors
        • Surufatinib Combined With Temozolomide and S-1
        • Beijing, Beijing, China
          Cancer Institute and Hospital, Chinese Academy of Medical Scienc
        Sep 8, 2023

        NHWD-870 in Advanced Solid Tumors or Lymphomas Carrying NUT

        Recruiting
        • Advanced Solid Tumors or Lymphomas
        • Changsha, Hunan, China
          Hunan Provincal Tumor Hospital
        Oct 5, 2023

        Refractory Solid Tumors, Relapsed Solid Tumors Trial in Beijing (KSX01-TCRT cell therapy)

        Recruiting
        • Refractory Solid Tumors
        • Relapsed Solid Tumors
        • KSX01-TCRT cell therapy
        • Beijing, China
          Cancer Institute and Hospital, Chinese Academy of Medical Scienc
        Nov 21, 2023

        Solid Tumors Trial (GS-9911, Zimberelimab)

        Not yet recruiting
        • Solid Tumors
        • (no location specified)
        Oct 9, 2023

        Her2-positive/Low-expression Urinary and Digestive Tract Tumors Trial in Beijing (BL-M07D1)

        Not yet recruiting
        • Her2-positive/Low-expression Urinary and Digestive Tract Tumors
        • Beijing, Beijing, China
          Cancer Hospital, Chinese Academy of Medical Sciences
        Sep 8, 2023

        Advanced Solid Tumors Trial (AMG 355, Pembrolizumab)

        Not yet recruiting
        • Advanced Solid Tumors
        • (no location specified)
        Nov 9, 2023

        Neuroendocrine Carcinomas, Neuroendocrine Tumors, Carcinoma, Neuroendocrine Trial run by the National Cancer Institute (NCI)

        Not yet recruiting
        • Neuroendocrine Carcinomas
        • +4 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Sep 22, 2023

        Imaging Features in Invasiveness and Prognosis of Pituitary

        Recruiting
        • Pituitary Adenoma
        • Neuroendocrine Tumors
        • diagnosed and treated reasonably according to the clinical guidelines and clinical pathways
        • Guangzhou, Guangdong, China
          endocrinology department of the first affiliated hospital of Sun
        Aug 24, 2023

        Regional Anesthesia, Pain Control, Microwave Ablation Trial in Chengdu (HHB+TAPB+and LA, HHB+LA, TAPB+LA)

        Recruiting
        • Regional Anesthesia
        • +3 more
        • HHB+TAPB+and LA
        • +2 more
        • Chengdu, Sichuan, China
          Sichuan cancer hospital
        Aug 12, 2023

        Advanced Solid Tumors With Neuroendocrine Differentiation Trial (surufatinib?serplulimab)

        Not yet recruiting
        • Advanced Solid Tumors With Neuroendocrine Differentiation
        • (no location specified)
        Nov 27, 2023

        Solid Tumors Trial (IBR854 Cell Injection)

        Not yet recruiting
        • Solid Tumors
        • IBR854 Cell Injection
        • (no location specified)
        Aug 14, 2023

        Advanced Solid Tumors Trial (SHR-1826)

        Not yet recruiting
        • Advanced Solid Tumors
        • (no location specified)
        Oct 16, 2023

        GT316,Solid Tumors,Adult Trial in Zhengzhou (GT316)

        Recruiting
        • GT316,Solid Tumors,Adult
        • GT316
        • Zhengzhou, Henan, China
          The First Affiliated Hospital of Zhengzhou University
        Oct 16, 2023

        Metastatic Solid Tumors, Advanced Solid Tumors Trial (MK-0472, Pembrolizumab)

        Not yet recruiting
        • Metastatic Solid Tumors
        • Advanced Solid Tumors
        • (no location specified)
        May 2, 2023

        Advanced Solid Tumors Trial (SKB410 for injection)

        Not yet recruiting
        • Advanced Solid Tumors
        • SKB410 for injection
        • (no location specified)
        Jun 13, 2023